Company
Perth, WA
Every investor coverage indicates participated in a round Little Green Pharma raised.
Investors whose own portfolio pages list Little Green Pharma, even though we haven't found any coverage of the round yet.
| Investor | Listed on |
|---|---|
| Gandel Invest | its portfolio page ↗ |
Companies Little Green Pharma acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
| Name | Role | Sources |
|---|---|---|
| Fleta Solomon | CEO | @AuManufacturing |
Stories naming Little Green Pharma. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Roundup of manufacturing briefs: Rio Tinto's quarterly output, Respiri's fresh placement, Archer's CEO exit, Amaero's US revenue, a retired UNSW satellite, Little Green Pharma's record quarter, OKA's investor group and MicroTau job ads.
Startup News recaps its most-read WA startup stories for the June quarter and the 2021-22 financial year, listing funding raises, acquisitions and other headlines that drew readers.
Techboard's annual report finds Australian early-stage startup funding passed $10 billion in FY21, up 64%, while WA companies attracted just $50 million, with ASX raises dominating and female founders' funding share falling.
Roundup of manufacturing updates: a psychedelics licence for a cannabis producer, a hydrogen grant, patents, a wellness brand acquisition, government program support, and a Turkish diagnostic distribution deal.
Perth medicinal cannabis producer Little Green Pharma has floated on the ASX through a $10 million IPO, with shares dipping on debut despite announcing a UK supply agreement and a licensing partnership with Curtin University.